L'Arbresle, France

Bernard J Montagnon

This inventor holds 3 USPTO granted patents. Top assignees: Institut Merieux, Societe Anonyme Dite: Institut Merueux, Other. Active years: 1985-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard J Montagnon. Retrieved from https://idiyas.com/inventor/bernard-j-montagnon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • 69 210 L'Arbresle, FR (1987)
  • L'Arbresle, FR (1985 - 1991)

Company Filing History:


Years Active: 1985-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Bernard J Montagnon

Introduction

Bernard J Montagnon is a notable inventor based in L'Arbresle, France. He has made significant contributions to the field of vaccine stabilization and production. With a total of 3 patents, his work has had a considerable impact on public health.

Latest Patents

One of Montagnon's latest patents is focused on stabilizing vaccines. This process involves using a compound with a specific general formula to stabilize attenuated lyophilized vaccines. Another important patent is for the large-scale production of rabies vaccine. This method utilizes a VERO cell strain and a liquid nutritive medium, allowing for efficient production in biogenerators of increasing volume.

Career Highlights

Throughout his career, Montagnon has worked with various companies, including Institut Merueux. His innovative approaches have led to advancements in vaccine technology, which are crucial for combating infectious diseases.

Collaborations

Montagnon has collaborated with notable individuals in his field, including Bernard J Fanget and Tadeusz J Wiktor. These partnerships have further enhanced his research and development efforts.

Conclusion

Bernard J Montagnon's contributions to vaccine stabilization and production exemplify his dedication to improving public health through innovation. His patents and collaborations reflect a commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…